Keros Therapeutics, Inc.KROSNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
+14.0%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.17M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $605000.00 | -96.5% |
| 2019 | $17.35M | +71.6% |
| 2018 | $10.11M | - |